Literature DB >> 24853201

Novel frame shift mutations ('A' deletion) observed in exon 9 of Wilms' tumor (WT1) gene in a patient reported with glomerulosclerosis.

Santhosh Kumar Pasupuleti1, Venkatesh Katari1, Srikanth Lokanathan1, Venkateswara Prasad Uppu1, Syama Sundar Thummaginjala2, Ram Prasad Reddy Akkamgari2, Tyagi Ayapati2, Radhika Kottu3, Venkata Gurunadha Krishna Sarma Potukuchi4.   

Abstract

Wilms' tumor-suppressor gene-1 (WT1) is a transcription factor that contains four zinc-finger motifs at the C-terminus and plays a crucial role in kidney and gonad development. We have identified primitive glomeruloid formation using immunohistochemistry in a patient who was clinically diagnosed with a Wilms' tumor. In order to understand the involvement of mutations in the WT1 gene, the genomic DNA was isolated from peripheral blood of the patient (18/F). Exon 9 of the WT1 gene was amplified and sequenced. The obtained sequence was BLAST searched against the transcript variants (TV) of the WT1 gene. An amplified exon 9 sequence of the WT1 gene showing similarity with exon 9 of TV-A, F and exon 10 of TV-B, D and E with a deletion of single nucleotide 'A' causing frame shift in the 4th zinc finger domain of the WT1 protein resulted in Wilms' tumor condition. The deletion position is variable with different transcript variants and they are present at: for TV-A c.1592delA, p.468, for TV-F c.1053delA, p.259, for TV-B c.1643delA, p.485, for TV-D c.1652 delA, p.488, and for TV-E c.1095delA, p.273; all these variations resulted in frame shift mutation. In order to substantiate these results in silico analysis was carried out; the structural superimposition of wild type and mutant WT1 structures showed that the mutated region exhibited a different confirmation with RMSD of 1.759Å. Therefore, these results conclusively explain the mutation in the WT1 gene that leads to structural changes contributing to glomerulosclerosis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Frame shift mutation; Immunohistochemistry; RMSD; Wilms' tumor

Mesh:

Substances:

Year:  2014        PMID: 24853201     DOI: 10.1016/j.gene.2014.05.037

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Novel mutations in the RING-finger domain of BRCA1 gene in clinically diagnosed breast cancer patients.

Authors:  Pasupuleti Santhosh Kumar; Lokanathan Srikanth; K Sudheer Reddy; Potukuchi Venkata Gurunadha Krishna Sarma
Journal:  3 Biotech       Date:  2020-01-13       Impact factor: 2.406

2.  Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients.

Authors:  Chodimella Chandrasekhar; Pasupuleti Santhosh Kumar; Potukuchi Venkata Gurunadha Krishna Sarma
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.